Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,080 public trials 582 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT01251575

Conditions
Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, +67 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer

NCT02391480

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Breast Cancer, +47 more
Locations
  • Scottsdale Healthcare /ID# 132963 Scottsdale, Arizona, United States
  • City of Hope /ID# 154053 Duarte, California, United States
  • UC Davis Comp Cancer Ctr /ID# 154644 Sacramento, California, United States
  • Yale University /ID# 136982 New Haven, Connecticut, United States
View Trial Details
Completed

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

NCT02189343

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +18 more
Locations
  • UT Southwestern Medical Center Simmons Comprehensive Cancer Center Dallas, Texas, United States
  • CTRC at The UT Health Science Center at San Antonio San Antonio, Texas, United States
  • University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

NCT00689936

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of AL Birmingham Birmingham, Alabama, United States
  • Cedar Sinai Medical Center Dept of Medicine Los Angeles, California, United States
  • University of California, San Francisco- California San Francisco, California, United States
  • Stanford University Stanford Stanford, California, United States
View all 288 locations
View Trial Details
Completed

A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma

NCT00622336

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Republican Clinical Hospital #1 Izhevsk, Russia
  • Nizhny Novgorod Clinical Hospital n.a.Semashko Nizhny Novgorod, Russia
  • Novosibirsk State Regional Clinical Novosibirsk, Russia
  • Samara Regional Clinical Hospital Samara, Russia
View Trial Details

Related conditions